Michiel Vlaming

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

Journal: European urology

Published: October 23, 2025

Expected costs and benefits of genetic counselling and germline genetic testing in metastatic prostate cancer.

Expected costs and benefits of genetic counselling and germline genetic testing in metastatic prostate cancer.

Journal: Human genetics

Published: October 07, 2025

Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer.

Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer.

Journal: BJU international

Published: September 02, 2025

AI-based prediction of molecular aberrations in prostate cancer using digital pathology: A systematic review.

AI-based prediction of molecular aberrations in prostate cancer using digital pathology: A systematic review.

Journal: Critical reviews in oncology/hematology

Published: July 02, 2025

Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway.

Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway.

Journal: International journal of cancer

Published: February 27, 2025

Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer.

Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer.

Journal: Prostate cancer and prostatic diseases

Published: May 29, 2024

Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relatives.

Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relatives.

Journal: Familial cancer

Published: December 15, 2023

Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting.

Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting.

Journal: European urology open science

Published: November 23, 2022

Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.

Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.

Journal: BMC cancer

Published: September 08, 2022

Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients.

Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients.

Journal: British journal of cancer

Published: May 23, 2022

The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care-A Systematic Review.

The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care-A Systematic Review.

Journal: Cancers

Published: January 14, 2022

Survival after radical cystectomy: Progressive versus De novo muscle invasive bladder cancer.

Survival after radical cystectomy: Progressive versus De novo muscle invasive bladder cancer.

Journal: Cancer treatment and research communications

Published: September 12, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026